News and Trends 29 Apr 2022 Denmark Recruits Lifebit to Boost Personalized Medicine with Genomics The Danish National Genome Center has teamed up with the UK firm Lifebit to improve the access and sharing of genomic data as the nation moves towards the adoption of personalized medicine. Personalized medicine is capturing the attention of healthcare authorities across the world. By harvesting genome sequences from patient populations, researchers can mine vast […] April 29, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Apr 2022 OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll the development of small molecules against so-called ‘undruggable’ targets, including one that sank Quench Bio last year. In 2020, Quench Bio captured the imagination of investors with the US firm’s ambition to develop a new class of anti-inflammatory drugs. The […] April 28, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 27 Apr 2022 Cancer Research UK Deploys €700M to Foster Oncology Startups In a show of strength after an income squeeze during the Covid-19 pandemic, the charity Cancer Research UK has dedicated €711M (£600M) to setting up a new innovation arm and seed fund designed to speed up the commercialization of oncology innovation. For decades, Cancer Research UK (CRUK) has played a pivotal role in nurturing advances […] April 27, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 25 Apr 2022 Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from the investment firm Syncona. The mission is to develop the first drugs to safeguard heart muscle from damage during heart attacks. A sudden heart attack, also known as acute myocardial infarction, happens when the flow of blood to the heart […] April 25, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Opinion 25 Apr 2022 Cloud Computing Can Help Life Sciences Catch Up Before It’s Too Late Biotechnology has the power to tackle global threats such as pandemics and climate change, but antiquated experimental and data collection methods are holding it back. Guy Levy-Yurista, CEO of the experiment platform developer Synthace, explains how cloud computing could accelerate the efforts of biotech companies to solve the big problems. There is a sundial in […] April 25, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 22 Apr 2022 European Biotech Investors Brace for Volatility in 2022 After gathering huge investment funds in 2021, European biotech investors took a breather in the first quarter of 2022, with the plan to steadily fund private biotechs amid a tumultuous public market. The last two years have seen a record-breaking amount of money flowing to biotech investors, with almost €10B reaching European life science funders […] April 22, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 20 Apr 2022 Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights A Covid-19 vaccine developed by the French company Valneva has received the green light from the UK’s drug regulator. The EMA, meanwhile, is proving harder to convince. The UK’s relationship with the French vaccine developer Valneva has run hot and cold over the past two years. In 2020, the UK government invested in Valneva’s manufacturing […] April 20, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 19 Apr 2022 How Augmented Reality Strengthens Biotech Manufacturing Biotech and pharma companies are starting to implement augmented reality technologies at their manufacturing facilities, bringing forth a whole new world of possibilities. The Covid-19 pandemic has been a catalyst for embracing new ways of working. Travel restrictions and limited access to facilities have pushed the adoption of technologies that enhance remote work. This is […] April 19, 2022 - 8 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
In Depth 13 Apr 2022 Cultured Meat Is Coming Soon: Here’s What You Need to Know Cultured meat promises to change the way we eat and help solve some of the big problems of a crowded planet. When will it be on our plate and how will this technology impact the world? In a couple of years, your food might be served with meat that has been grown from animal cells […] April 13, 2022 - 12 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2022 The Top European Biotech Investments in March 2022 As wars and inflation buffet European markets, private biotech companies raised fewer investments in March 2022 than in previous months. The top private rounds went to firms developing cancer treatments and microbiome therapeutics. The first quarter of 2022 has seen a gradual decline of biotech investments in the European space. The total raised by European […] April 11, 2022 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 Apr 2022 Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs The UK-US venture capitalist Epidarex Capital has led an €11M (£9M) funding round raised by the Edinburgh-based Kynos Therapeutics, which aims to develop anti-inflammatory treatments by blocking an emerging metabolic target. Much of the UK’s biotech innovation is concentrated in the so-called Golden Triangle, encompassing the hubs of Cambridge, Oxford, and London. In 2020, Epidarex […] April 8, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 6 Apr 2022 Immunocore Approvals Open Door for TCR Cancer Drugs The EU has followed the FDA in granting market approval to Kimmtrak, the first-ever bispecific drug based on a cancer-hunting protein called a T-cell receptor (TCR). These regulatory wins by the UK firm Immunocore pave the way for other treatments deploying TCRs. TCRs have become a hot topic in immuno-oncology. Many companies are developing cancer […] April 6, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email